CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Reconciliation of net income to cash provided by operating activities:
Net income	$ 128,797	$ 155,962
Add (deduct):
Depreciation and amortization	28,037	13,249
Adjustments for bad debt provisions	(157)	846
Net realized and unrealized losses (gains)	7,820	(14,929)
Amortization of net premium on debt securities investments	1,382	1,904
Payments for title losses less than provisions	16,902	26,222
Adjustments for insurance recoveries of title losses	220	0
Decrease (increase) in receivables – net	2,907	(22,366)
Increase in other assets – net	(6,720)	(3,327)
Decrease in accounts payable and other liabilities – net	(68,475)	(15,390)
Change in net deferred income taxes	515	4,122
Net income from equity method investments	(1,860)	(3,412)
Dividends received from equity method investments	2,150	1,739
Stock-based compensation expense	6,440	5,879
Other – net	229	(47)
Cash provided by operating activities	118,187	150,452
Investing activities:
Proceeds from sales of investments in securities	28,769	14,744
Proceeds from matured investments in debt securities	23,521	51,034
Purchases of investments in securities	(117,913)	(89,198)
Net (purchases) sales of short-term investments	(189)	2,747
Purchases of property and equipment, and real estate	(26,226)	(16,430)
Proceeds from sale of property and equipment and other assets	1,033	10,583
Cash paid for acquisition of businesses	(23,310)	(131,906)
Cash paid for acquisition of equity method investment	(69)	(16,080)
Other – net	3,242	855
Cash used by investing activities	(111,142)	(173,651)
Financing activities:
Proceeds from notes payable	5,721	181,755
Payments on notes payable	(44,553)	(157,662)
Distributions to noncontrolling interests	(9,483)	(7,253)
Repurchases of Common Stock	(2,551)	(2,002)
Proceeds from stock option and employee stock purchase plan exercises	2,713	181
Cash dividends paid	(20,258)	(17,688)
Payment of contingent consideration related to acquisitions	(15,997)	(75)
Purchase of remaining interest in consolidated subsidiaries	0	(5,616)
Other - net	94	(777)
Cash used by financing activities	(84,314)	(9,137)
Effects of changes in foreign currency exchange rates	(3,340)	195
Change in cash and cash equivalents	(80,609)	(32,141)
Cash and cash equivalents at beginning of period	485,919	432,683
Cash and cash equivalents at end of period	$ 405,310	$ 400,542